Wellgistics Health (WGRX) announced the execution of a definitive joint venture agreement with Kare PharmTech’s wholly owned subsidiary, Kare Rx Hub, an artificial intelligence-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs. The execution of the joint venture formalizes the previously announced non-binding letter of intent and represents a significant milestone in aligning both organizations technology platforms and operational teams into a unified ecosystem designed to accelerate patient access and improve the efficiency of pharmaceutical commercialization.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGRX:
- Wellgistics Health Ends Settlement, Shifts Financing Strategy
- Wellgistics Health Raises Capital via Private Note Financing
- Wellgistics enters LOI to evaluate potential acquisition of Neuritek
- Wellgistics Health converts $2M in deferred compensation equity at 20c per share
- Wellgistics: ‘Actively preparing’ telemedicine, diagnostic testing strategies